MatthewBakerMDMS
Rheumatology • Stanford, CAAssistant Professor in Rheumatology at Stanford University
Dr. Baker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-725-8418
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Rheumatology, 2016
Massachusetts General HospitalResidency, Internal Medicine, 2011 - 2014
Harvard Medical SchoolClass of 2011
Certifications & Licensure
CA State Medical License 2014 - 2026
OR State Medical License 2020 - 2022
MA State Medical License 2011 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Clinical Trials
- BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome Start of enrollment: 2022 Feb 01
- Zanubrutinib in Patients With IgG4-Related Disease Start of enrollment: 2022 Aug 01
Publications & Presentations
PubMed
- 3 citationsRepurposing drugs for the treatment of osteoarthritis.Wilson Kuswanto, Matthew C Baker
Osteoarthritis and Cartilage. 2024-08-01 - 1 citationsAnnual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based...Titilola Falasinnu, Di Lu, Matthew C Baker
The Lancet. Rheumatology. 2024-08-01 - 6 citationsA double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis.Matthew C Baker, Audra Horomanski, Yiwen Wang, Yuhan Liu, Shima Parsafar
Rheumatology. 2024-05-02
Press Mentions
FSR Expands Scientific Advisory Board to Improve Research, CareSeptember 10th, 2024- Foundation for Sarcoidosis Research Expands Scientific Advisory Board with 14 New Experts to Enhance Sarcoidosis Research and Patient CareAugust 28th, 2024
- Metformin Linked to Reduced Osteoarthritis RiskApril 24th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
